Galectin Therapeutics reported $29.73M in Loan Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Bristol Myers Squibb BMY:US USD 36.97B 141M
Galectin Therapeutics GALT:US USD 29.73M 230K
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
YTE INCY:US USD 30.48M 681K